Your search for proton pump inhibitor returned 8 results

Proton pump inhibitor use is associated with shorter survival among patients with non-small cell lung cancer treated with pembrolizumab monotherapy.

Is the use of proton pump inhibitors associated with empyema and lung abscess? Presenters at CHEST 2022 analyzed a large data base to address this question.

Is the use of proton pump inhibitors associated with empyema and lung abscess? Presenters at CHEST 2022 analyzed a large data base to address this question.

Clear management guidelines are needed for AKI during immune checkpoint inhibitor therapy, according to investigators.

No significant association seen for lesser durations of proton pump inhibitor use.

By simplifying the dosing regimen, the Company hopes to improve patient adherence and treatment outcomes.

The findings highlight the value of routine medication assessment.

Researchers investigated whether short- or long-acting glucagon-like peptide 1 receptor agonists were associated with developing GERD.